Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease

Respiration

Volumn 74, Issue 5, 2007, Pages 558-564

  Shimizu, Yasuo ^a,b   Dobashi, Kunio ^a   Zhao, Jian Jun ^a   Kawata, Tadayoshi ^a   Ono, Akihiro ^a   Yanagitani, Noriko ^a   Kaira, Kyoichi ^a   Utsugi, Mitsuyoshi ^a   Hisada, Takeshi ^a   Ishizuka, Tamotsu ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Asthma; Exhaled breath condensate; Gastroesophageal reflux and lung disease; Lansoprazole; Proton pump inhibitor

Indexed keywords

8 ISOPROSTANE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ACIDITY; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; OXIDATIVE STRESS; PH; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; COMORBIDITY; DINOPROST; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTON PUMPS;

EID: 34547644624     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101437     Document Type: Article

References (33)

1. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfeld J, Jobsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin AC, Redington AE, Reinhold P, van Rensen EL, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C, Wirtz H; ATS/ERS Task Force on Exhaled Breath Condensate: Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26:523-548.
2. Davidsson A, Naidu Sjosward K, Lundman L, Schmekel B: Quantitative assessment and repeatability of chlorine in exhaled breath condensate. Respiration 2005;72:529-536.
3. Vaughan J, Ngamtrakulpanit L, Pajewski TN, Turner R, Nguyen TA, Smith A, Arban P, Hom S, Gaston B, Hunt J: Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 2003;22:889-894.
4. Ricciardolo FL, Gaston B, Hunt J: Acid stress in the pathology of asthma. J Allergy Clin Immunol 2004;113:610-619.
5. Luk CK, Dulfano MJ: Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants. Clin Sci (Lond) 1983;64:449-451.
6. Bevan S, Geppetti P: Protons: small stimulants of capsaicinsensitive sensory nerves. Trends Neurosci 1994;17:509-512.
7. Rahman I, Biswas SK, Kode A: Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006;533:222-239.
8. 2+ handling and Rho/ROCK signaling. Am J Physiol Lung Cell Mol Physiol 2006;291:L1177-L1184.
9. Iizuka K, Shimizu Y, Tsukagoshi H, Yoshii A, Harada T, Dobashi K, Murozono T, Nakazawa T, Mori M: Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs. Eur J Pharmacol 2000;13:406:273-279.
10. 2+ sensitization. Am J Respir Cell Mol Biol 1999;20:1190-1200.
11. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ: Increased 8-isoprostane, a marker of oxidative stress, in exhaled air condensate of asthma patients. Am J Respir Crit Care Med 1999;160:216-220.
12. Biernacki WA, Kharitonov SA, Barnes PJ: Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003;58:294-298.
13. Carpenter CT, Price PV, Christman BW: Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998;114:1653-1659.
14. Kharitonov SA, Barnes PJ: Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001;163:1693-1722.
15. Harding SM: Gastroesophageal reflux and asthma: insight into the association. J Allergy Clin Immunol 1999;104:251-259.
16. Shimizu Y, Dobashi K, Kobayashi S, Ohki I, Tokushima M, Kusano M, Kawamura O, Shimoyama Y, Utsugi M, Mori M: High prevalence of gastroesophageal reflux disease with minimal mucosal change in asthmatic patients. Tohoku J Exp Med 2006;209:329-336.
17. Carlsson R, Dent J, Bolling-Sternevald F, Johnsson F, Junghard O, Lauritsen K, Riley S, Lundell L: The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-1029.
18. Tuchman DN, Boyle JT, Pack AI, Scwartz J, Kokonos M, Spitzer AR, Cohen S: Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 1984;87:872-881.
19. Altschuler SM: Laryngeal and respiratory protective reflexes. Am J Med 2001;111: 90S-94S.
20. Shimizu Y, Dobashi K, Kobayashi S, Ohki I, Tokushima M, Kusano M, Kawamura O, Shimoyama Y, Utsugi M, Sunaga N, Ishizuka T, Mori M: A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. Tohoku J Exp Med 2006;209:181-189.
21. Littner MR, Leung FW, Ballard ED 2nd, Huang B, Samra NK; Lansoprazole Asthma Study Group: Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005;128:1128-1135.
22. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J: Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292:1955-1960.
23. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. Bethesda, National Institutes of Health, 2003.
24. Tate S, MacGregor G, Davis M, Innes JA, Greening AP: Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 2002;57:926-929.
25. Hamamto J, Kohrogi H, Kawano O, Iwagoe H, Fujii K, Hirata N, Ando M: Esophageal stimulation by hydrochloric acid causes neurogenic inflammation in the airways in guinea pigs. J Appl Physiol 1997;82:738-745.
26. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S: pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002;165:1364-1370.
27. Cheng L, Cao W, Behar J, Biancani P, Harnett KM: Inflammation induced changes in arachidonic acid metabolism in cat LES circular muscle. Am J Physiol Gastrointest Liver Physiol 2005;288:G787-G797.
28. Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TA, Gaston B: Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy 2005;35:1180-1185.
29. Carpagnano GE, Resta O, Ventura MT, Amoruso AC, Di Gioia G, Giliberti T, Refolo L, Foschino-Barbaro MP: Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma. J Intern Med 2006;259:323-331.
30. Ohara T, Arakawa T: Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells. Dig Dis Sci 1999;44:1710-1715.
31. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R: Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-459.
32. Gorska-Ciebiada M, Ciebiada M, Gorska MM, Gorski P, Grzelewska-Rzymowska I: Intercellular adhesion molecule 1 and tumor necrosis factor α in asthma and persistent allergic rhinitis: relationship with disease severity. Ann Allergy Asthma Immunol 2006;97:66-72.
33. Becker JC, Grosser N, Waltke C, Schulz S, Erdmann K, Domschke W, Schröder H, Pohle T: Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochem Biophys Res Commun 2004;315:509-516.